Home | Publications | Generic Drugs | Patent Reports place holder

Patent Reports

In this section you will find drug-specific Pipeline™ Selector reports which include general drug information, a key patent indicator with click through to patent documents, first to market authorisation, and graphical analysis of patent category distribution, top patent applicants and patent filing trends.

Stay up-to-date with new products added to this category

place holder place holder place holder place holder place holder place holder

Patent Reports


Title Sort Publication Date Sort Price Sort
place holder


Pregabalin: Pipeline Developer
Patent Report

Ongoing £2080
Personal Protective Products in Healthcare
Disposable Gloves Worldwide

April 2007 £990
All Other Ambulatory Health Care Services in the US
IBISWorld Industry Report

February 2007 £325
Risperidone: Pipeline™ Developer
Patent Report

Ongoing £1825
Rivastigmine: Pipeline™ Developer
Patent Report

Ongoing £1825
Ropinirole: Pipeline™ Developer
Patent Report

Ongoing £2120
Sertraline: Pipeline™ Developer
Patent Report

Ongoing £2120
Roxithromycin: Pipeline™ Developer
Patent Report

Ongoing £2120
Ropivacaine: Pipeline™ Developer
Patent Report

Ongoing £2120
Risedronic Acid: Pipeline™ Developer
Patent Report

Ongoing £2120
Raloxifene: Pipeline™ Developer
Patent Report

Ongoing £2460
Rabeprazole: Pipeline™ Developer
Patent Report

Ongoing £2460
Ramipril: Pipeline™ Developer
Patent Report

Ongoing £2120
Repaglinide: Pipeline™ Developer
Patent Report

Ongoing £1825
Riluzole: Pipeline™ Developer
Patent Report

Ongoing £1825
Simvastatin: Pipeline™ Developer
Patent Report

Ongoing £1825
Sumatriptan: Pipeline™ Developer
Patent Report

Ongoing £2120
Tacrolimus: Pipeline™ Developer
Patent Report

Ongoing £2460
Zolmitriptan: Pipeline™ Developer
Patent Report

Ongoing £2120
Temozolomide: Pipeline™ Developer
Patent Report

Ongoing £1825
Cyclosporin (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Detomidine (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Deracoxib (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Zoledronic Acid: Pipeline™ Developer
Patent Report

Ongoing £2120
Venlafaxine: Pipeline™ Developer
Patent Report

Ongoing £2120
Terbinafine: Pipeline™ Developer
Patent Report

Ongoing £1825
Tamsulosin: Pipeline™ Developer
Patent Report

Ongoing £1825
Tolterodine: Pipeline™ Developer
Patent Report

Ongoing £1825
Topiramate: Pipeline™ Developer
Patent Report

Ongoing £1825
Valaciclovir: Pipeline™ Developer
Patent Report

Ongoing £2460
Trandolapril: Pipeline™ Developer
Patent Report

Ongoing £2120
Quinapril: Pipeline™ Developer
Patent Report

Ongoing £2120
Pravastatin: Pipeline™ Developer
Patent Report

Ongoing £2120
Mirtazapine: Pipeline™ Developer
Patent Report

Ongoing £1825
Midazolam: Pipeline™ Developer
Patent Report

Ongoing £1825
Mometasone: Pipeline™ Developer
Patent Report

Ongoing £2120
Montelukast: Pipeline™ Developer
Patent Report

Ongoing £1825
Nateglinide: Pipeline™ Developer
Patent Report

Ongoing £1825
Naratriptan: Pipeline™ Developer
Patent Report

Ongoing £2120
Meropenem: Pipeline™ Developer
Patent Report

Ongoing £2460
Meloxicam: Pipeline™ Developer
Patent Report

Ongoing £1825
Lercanidipine: Pipeline™ Developer
Patent Report

Ongoing £2460
Leflunomide: Pipeline™ Developer
Patent Report

Ongoing £2120
Letrozole: Pipeline™ Developer
Patent Report

Ongoing £1825
Levetiracetam: Pipeline™ Developer
Patent Report

Ongoing £1825
Losartan: Pipeline™ Developer
Patent Report

Ongoing £2460
Levofloxacin: Pipeline™ Developer
Patent Report

Ongoing £2460
Nebivolol: Pipeline™ Developer
Patent Report

Ongoing £2120
Nicorandil: Pipeline™ Developer
Patent Report

Ongoing £1825
Paroxetine: Pipeline™ Developer
Patent Report

Ongoing £2120
Pantoprazole: Pipeline™ Developer
Patent Report

Ongoing £2460
Perindopril: Pipeline™ Developer
Patent Report

Ongoing £2120
Pioglitazone: Pipeline™ Developer
Patent Report

Ongoing £2460
Doxorubicin: Pipeline™ Selector
Patent Report

Ongoing £210
Pramipexole: Pipeline™ Developer
Patent Report

Ongoing £1825
Paclitaxel: Pipeline™ Developer
Patent Report

Ongoing £2800
Oxaliplatin: Pipeline™ Developer
Patent Report

Ongoing £2120
Olanzapine: Pipeline™ Developer
Patent Report

Ongoing £2120
Octreotide: Pipeline™ Developer
Patent Report

Ongoing £2120
Omeprazole: Pipeline™ Developer
Patent Report

Ongoing £2800
Ondansetron: Pipeline™ Developer
Patent Report

Ongoing £1825
Orlistat: Pipeline™ Developer
Patent Report

Ongoing £1825
Quetiapine: Pipeline™ Developer
Patent Report

Ongoing £2120
Imidacloprid (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Bosentan: Pipeline™ Selector
Patent Report

Ongoing £210
Bimatoprost: Pipeline™ Selector
Patent Report

Ongoing £210
Buprenorphine: Pipeline™ Selector
Patent Report

Ongoing £210
Dasatinib: Pipeline™ Selector
Patent Report

Ongoing £210
Eptifibatide: Pipeline™ Selector
Patent Report

Ongoing £210
Eprosartan: Pipeline™ Selector
Patent Report

Ongoing £210
Aliskiren: Pipeline™ Selector
Patent Report

Ongoing £210
Vardenafil: Pipeline™ Selector
Patent Report

Ongoing £210
Moxifloxacin: Pipeline™ Selector
Patent Report

Ongoing £210
Moxifloxacin: Pipeline™ Developer
Patent Report

Ongoing £2460
Pyriproxyfen (Vet): Pipeline™ Developer
Patent Report

Ongoing £1790
Trastuzumab: Pipeline™ Developer
Patent Report

Ongoing £2745
Vardenafil: Pipeline™ Developer
Patent Report

Ongoing £2460
Trastuzumab: Pipeline™ Selector
Patent Report

Ongoing £210
Erlotinib: Pipeline™ Selector
Patent Report

Ongoing £210
Ertapenem: Pipeline™ Selector
Patent Report

Ongoing £210
Tazobactam: Pipeline™ Selector
Patent Report

Ongoing £210
Tadalafil: Pipeline™ Selector
Patent Report

Ongoing £210
Tigecycline: Pipeline™ Selector
Patent Report

Ongoing £210
Tiotropium Bromide: Pipeline™ Selector
Patent Report

Ongoing £210
Varenicline: Pipeline™ Selector
Patent Report

Ongoing £210
Travoprost: Pipeline™ Selector
Patent Report

Ongoing £210
Sunitinib: Pipeline™ Selector
Patent Report

Ongoing £210
Sevelamer: Pipeline™ Selector
Patent Report

Ongoing £210
Glatiramer: Pipeline™ Selector
Patent Report

Ongoing £210
Gefitinib: Pipeline™ Selector
Patent Report

Ongoing £210
Lapatinib: Pipeline™ Selector
Patent Report

Ongoing £210
Olmesartan: Pipeline™ Selector
Patent Report

Ongoing £210
Ritonavir: Pipeline™ Selector
Patent Report

Ongoing £210
Moxidectin (Vet): Pipeline™ Developer
Patent Report

Ongoing £2460
Imidacloprid (Vet): Pipeline™ Developer
Patent Report

Ongoing £2080
Zolmitriptan (vet): Pipeline™ Developer
Patent Report

Ongoing £2120
Tiletamine (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Candesartan: Pipeline™ Selector
Patent Report

Ongoing £210
Docetaxel: Pipeline™ Selector
Patent Report

Ongoing £210
Memantine: Pipeline™ Selector
Patent Report

Ongoing £210
Eplerenone: Pipeline™ Selector
Patent Report

Ongoing £210
Eletriptan: Pipeline™ Developer
Patent Report

Ongoing £2120
Aripiprazole: Pipeline™ Developer
Patent Report

Ongoing £2120
Omeprazole: Pipeline™ Selector
Patent Report

Ongoing £210
Fipronil (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Medetomidine (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Meloxicam (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Almotriptan: Pipeline™ Developer
Patent Report

Ongoing £2120
Pregabalin: Pipeline™ Selector
Patent Report

Ongoing £210
Rosiglitazone: Pipeline™ Selector
Patent Report

Ongoing £210
Rosiglitazone: Pipeline™ Developer
Patent Report

Ongoing £2460
Memantine: Pipeline™ Developer
Patent Report

Ongoing £1790
Valsartan: Pipeline™ Developer
Patent Report

Ongoing £2460
Doxorubicin: Pipeline™ Developer
Patent Report

Ongoing £2745
Gatifloxacin: Pipeline™ Selector
Patent Report

Ongoing £210
Fipronil (Vet): Pipeline™ Developer
Patent Report

Ongoing £2080
Meloxicam (vet): Pipeline™ Developer
Patent Report

Ongoing £1790
Eplerenone: Pipeline™ Developer
Patent Report

Ongoing £1790
Telmisartan: Pipeline™ Selector
Patent Report

Ongoing £210
Sirolimus: Pipeline™ Selector
Patent Report

Ongoing £210
Topotecan: Pipeline™ Selector
Patent Report

Ongoing £210
Candesartan: Pipeline™ Developer
Patent Report

Ongoing £2460
Docetaxel: Pipeline™ Developer
Patent Report

Ongoing £2745
Enrofloxacin (vet): Pipeline™ Selector
Patent Report

Ongoing £210
Latanoprost: Pipeline™ Developer
Patent Report

Ongoing £2120
Letrozole: Pipeline™ Selector
Patent Report

Ongoing £210
Lercanidipine: Pipeline™ Selector
Patent Report

Ongoing £210
Levetiracetam: Pipeline™ Selector
Patent Report

Ongoing £210
Levofloxacin: Pipeline™ Selector
Patent Report

Ongoing £210
Losartan: Pipeline™ Selector
Patent Report

Ongoing £210
Loratadine: Pipeline™ Selector
Patent Report

Ongoing £210
Leflunomide: Pipeline™ Selector
Patent Report

Ongoing £210
Latanoprost: Pipeline™ Selector
Patent Report

Ongoing £210
Glimepiride: Pipeline™ Selector
Patent Report

Ongoing £210
Gemcitabine: Pipeline™ Selector
Patent Report

Ongoing £210
Irinotecan: Pipeline™ Selector
Patent Report

Ongoing £210
Itraconazole: Pipeline™ Selector
Patent Report

Ongoing £210
Lansoprazole: Pipeline™ Selector
Patent Report

Ongoing £210
Lamotrigine: Pipeline™ Selector
Patent Report

Ongoing £210
Meloxicam: Pipeline™ Selector
Patent Report

Ongoing £210
Metronidazole: Pipeline™ Selector
Patent Report

Ongoing £210
Pantoprazole: Pipeline™ Selector
Patent Report

Ongoing £210
Paclitaxel: Pipeline™ Selector
Patent Report

Ongoing £210
Paroxetine: Pipeline™ Selector
Patent Report

Ongoing £210
Pergolide: Pipeline™ Selector
Patent Report

Ongoing £210
Pioglitazone: Pipeline™ Selector
Patent Report

Ongoing £210
Perindopril: Pipeline™ Selector
Patent Report

Ongoing £210
Orlistat: Pipeline™ Selector
Patent Report

Ongoing £210
Ondansetron: Pipeline™ Selector
Patent Report

Ongoing £210
Mirtazapine: Pipeline™ Selector
Patent Report

Ongoing £210
Midazolam: Pipeline™ Selector
Patent Report

Ongoing £210
Mometasone: Pipeline™ Selector
Patent Report

Ongoing £210
Montelukast: Pipeline™ Selector
Patent Report

Ongoing £210
Olanzapine: Pipeline™ Selector
Patent Report

Ongoing £210
Gabapentin: Pipeline™ Selector
Patent Report

Ongoing £210
Fosinopril: Pipeline™ Selector
Patent Report

Ongoing £210
Cabergoline: Pipeline™ Selector
Patent Report

Ongoing £210
Bicalutamide: Pipeline™ Selector
Patent Report

Ongoing £210
Calcipotriol: Pipeline™ Selector
Patent Report

Ongoing £210
Calcitriol: Pipeline™ Selector
Patent Report

Ongoing £210
Citalopram: Pipeline™ Selector
Patent Report

Ongoing £210
Carvedilol: Pipeline™ Selector
Patent Report

Ongoing £210
Atorvastatin: Pipeline™ Selector
Patent Report

Ongoing £210
Anastrozole: Pipeline™ Selector
Patent Report

Ongoing £210
Adapalene: Pipeline™ Selector
Patent Report

Ongoing £210
Acarbose: Pipeline™ Selector
Patent Report

Ongoing £210
Alendronic Acid: Pipeline™ Selector
Patent Report

Ongoing £210
Alfuzosin: Pipeline™ Selector
Patent Report

Ongoing £210
Amorolfine: Pipeline™ Selector
Patent Report

Ongoing £210
Amlodipine: Pipeline™ Selector
Patent Report

Ongoing £210
Clarithromycin: Pipeline™ Selector
Patent Report

Ongoing £210
Clobetasol Propionate: Pipeline™ Selector
Patent Report

Ongoing £210
Fexofenadine: Pipeline™ Selector
Patent Report

Ongoing £210
Famciclovir: Pipeline™ Selector
Patent Report

Ongoing £210
Finasteride: Pipeline™ Selector
Patent Report

Ongoing £210
Florfenicol (Vet): Pipeline™ Selector
Patent Report

Ongoing £210
Fluvoxamine: Pipeline™ Selector
Patent Report

Ongoing £210
Fluvastatin: Pipeline™ Selector
Patent Report

Ongoing £210
Ezetimibe: Pipeline™ Selector
Patent Report

Ongoing £210
Erythropoietin: Pipeline™ Selector
Patent Report

Ongoing £210
Desloratadine: Pipeline™ Selector
Patent Report

Ongoing £210
Clopidogrel: Pipeline™ Selector
Patent Report

Ongoing £210
Donepezil: Pipeline™ Selector
Patent Report

Ongoing £210
Dorzolamide: Pipeline™ Selector
Patent Report

Ongoing £210
Entacapone: Pipeline™ Selector
Patent Report

Ongoing £210
Pramipexole: Pipeline™ Selector
Patent Report

Ongoing £210
Pravastatin: Pipeline™ Selector
Patent Report

Ongoing £210
Clopidogrel: Pipeline™ Developer
Patent Report

Ongoing £2120
Clarithromycin: Pipeline™ Developer
Patent Report

Ongoing £2120
Desloratadine: Pipeline™ Developer
Patent Report

Ongoing £1825
Donepezil: Pipeline™ Developer
Patent Report

Ongoing £2120
Entacapone: Pipeline™ Developer
Patent Report

Ongoing £1825
Dorzolamide: Pipeline™ Developer
Patent Report

Ongoing £2120
Cladribine: Pipeline™ Developer
Patent Report

Ongoing £1825
Citalopram: Pipeline™ Developer
Patent Report

Ongoing £2120
Bisoprolol: Pipeline™ Developer
Patent Report

Ongoing £1490
Bicalutamide: Pipeline™ Developer
Patent Report

Ongoing £1825
Calcipotriol: Pipeline™ Developer
Patent Report

Ongoing £2120
Capecitabine: Pipeline™ Developer
Patent Report

Ongoing £2120
Cisatracurium Besylate: Pipeline™ Developer
Patent Report

Ongoing £1825
Carvedilol: Pipeline™ Developer
Patent Report

Ongoing £1825
Erythropoietin: Pipeline™ Developer
Patent Report

Ongoing £2460
Exemestane: Pipeline™ Developer
Patent Report

Ongoing £2120
Indapamide: Pipeline™ Developer
Patent Report

Ongoing £1825
Glimepiride: Pipeline™ Developer
Patent Report

Ongoing £1825
Irbesartan: Pipeline™ Developer
Patent Report

Ongoing £2460
Irinotecan: Pipeline™ Developer
Patent Report

Ongoing £2120
Lamotrigine: Pipeline™ Developer
Patent Report

Ongoing £1825
Isotretinoin: Pipeline™ Developer
Patent Report

Ongoing £2460
Gemcitabine: Pipeline™ Developer
Patent Report

Ongoing £2120
Gadopentetate: Pipeline™ Developer
Patent Report

Ongoing £1825
Fexofenadine: Pipeline™ Developer
Patent Report

Ongoing £2120
Famciclovir: Pipeline™ Developer
Patent Report

Ongoing £2120
Finasteride: Pipeline™ Developer
Patent Report

Ongoing £2120
Fluvastatin: Pipeline™ Developer
Patent Report

Ongoing £2460
Fosinopril: Pipeline™ Developer
Patent Report

Ongoing £2120
Azithromycin: Pipeline™ Developer
Patent Report

Ongoing £2120
Atorvastatin: Pipeline™ Developer
Patent Report

Ongoing £2120
Ropinirole: Pipeline™ Selector
Patent Report

Ongoing £210
Rivastigmine: Pipeline™ Selector
Patent Report

Ongoing £210
Roxithromycin: Pipeline™ Selector
Patent Report

Ongoing £210
Sertraline: Pipeline™ Selector
Patent Report

Ongoing £210
Sumatriptan: Pipeline™ Selector
Patent Report

Ongoing £210
Simvastatin: Pipeline™ Selector
Patent Report

Ongoing £210
Risperidone: Pipeline™ Selector
Patent Report

Ongoing £210
Risedronic Acid: Pipeline™ Selector
Patent Report

Ongoing £210
Quinapril: Pipeline™ Selector
Patent Report

Ongoing £210
Quetiapine: Pipeline™ Selector
Patent Report

Ongoing £210
Raloxifene: Pipeline™ Selector
Patent Report

Ongoing £210
Ramipril: Pipeline™ Selector
Patent Report

Ongoing £210
Repaglinide: Pipeline™ Selector
Patent Report

Ongoing £210
Reboxetine: Pipeline™ Selector
Patent Report

Ongoing £210
Lansoprazole: Pipeline™ Developer
Patent Report

Ongoing £2120
Tacrolimus: Pipeline™ Selector
Patent Report

Ongoing £210
Adapalene: Pipeline™ Developer
Patent Report

Ongoing £2120
Zoledronic Acid: Pipeline™ Selector
Patent Report

Ongoing £210
Alendronic Acid: Pipeline™ Developer
Patent Report

Ongoing £2120
Amlodipine: Pipeline™ Developer
Patent Report

Ongoing £2120
Anastrozole: Pipeline™ Developer
Patent Report

Ongoing £1825
Amorolfine: Pipeline™ Developer
Patent Report

Ongoing £2120
Tamsulosin: Pipeline™ Selector
Patent Report

Ongoing £210
Venlafaxine: Pipeline™ Selector
Patent Report

Ongoing £210
Tolterodine: Pipeline™ Selector
Patent Report

Ongoing £210
Terbinafine: Pipeline™ Selector
Patent Report

Ongoing £210
Valsartan: Pipeline™ Selector
Patent Report

Ongoing £210
Topiramate: Pipeline™ Selector
Patent Report

Ongoing £210
Trandolapril: Pipeline™ Selector
Patent Report

Ongoing £210
Valaciclovir: Pipeline™ Selector
Patent Report

Ongoing £210
When Patients Becomes Plaintiffs
A Primer on Drug and Medical Device Liability

October 2006 £1095
place holder